These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12489918)

  • 1. Familial Lewy body diseases.
    Gwinn-Hardy K; Singleton AA
    J Geriatr Psychiatry Neurol; 2002; 15(4):217-23. PubMed ID: 12489918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.
    Gwinn-Hardy K; Mehta ND; Farrer M; Maraganore D; Muenter M; Yen SH; Hardy J; Dickson DW
    Acta Neuropathol; 2000 Jun; 99(6):663-72. PubMed ID: 10867800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease.
    Lockhart PJ; Kachergus J; Lincoln S; Hulihan M; Bisceglio G; Thomas N; Dickson D; Farrer MJ
    J Mol Neurosci; 2004; 24(3):337-42. PubMed ID: 15655258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
    Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset dementia with Lewy bodies.
    Takao M; Ghetti B; Yoshida H; Piccardo P; Narain Y; Murrell JR; Vidal R; Glazier BS; Jakes R; Tsutsui M; Spillantini MG; Crowther RA; Goedert M; Koto A
    Brain Pathol; 2004 Apr; 14(2):137-47. PubMed ID: 15193026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
    Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
    J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
    Kaplan B; Ratner V; Haas E
    J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of dementia with Lewy bodies: what are we missing?
    Meeus B; Theuns J; Van Broeckhoven C
    Arch Neurol; 2012 Sep; 69(9):1113-8. PubMed ID: 22635379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
    Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.